Active Pharmaceutical Ingredients (API) Market to Represent a Value of USD 239.8 Billion With CAGR Of 6.0% by 2025 | Million Insights

Wednesday, January 17, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

FELTON, California, January 17, 2018 /PRNewswire/ --

The global Active Pharmaceutical Ingredient (API) market

size was worth at USD 134.2 billion in the year 2015 which is anticipated to reach a value of USD 239.8 billion by 2025, with CAGR of 6.0%. Rising prevalence of chronic diseases such as neurological
diseases, cardiovascular diseases, can lead to the growth.

The key drivers can be the rising demand of efficient and rapid acting drugs and introduction of innovative drug production facility. Major key players are choosing for outsourcing the product from the developing regions such as India, Brazil and China, which also anticipated to drive the market.

Browse 95 page research report with TOC on "Global Active Pharmaceutical Ingredients (API) Market" at:

Based on synthesis type, the market is categorized into synthetic and biotech. Various methods are adopted by the manufacturing companies depending up on the complexity of the molecule required. Synthetic drugs are manufactured on the basis of organic chemistry in contrast to biotechnology based drugs, which are produced by utilizing molecular techniques. Further classification of biotech segment is recombinant proteins, monoclonal antibodies and vaccines.

In 2015, synthetic segment held the largest share. The key factors for the biotech APIs segment growth are large R&D investment for new biosimilars, increasing demand for protein-based medicines, and rising focus of key manufacturers toward biological drugs.

Based on the type of manufacturer, it is categorized into outsourced or merchant or in-house or captive APIs. According to market estimates, in 2015, in-house APIs was the largest segment and outsourced APIs are anticipated to be the fastest growing market.

Based on the type, APIs are classified into innovative and generics. Branded products come under innovative type, whereas the generic drugs are the ones, which are available OTC (over the counter). Owing of high rate of prescription, high drug development initiatives, and high price, the innovative APIs segment dominated in 2015.

Cancer, neurological disorders & CNS, endocrinal disorders and cardiovascular diseases are some of the major applications of the API. In 2015, CVD (cardiovascular diseases) dominated the market owing to its high rate of prevalence and high product availability. CVD has been reported as the major cause of death in the U.S since many years.

Browse reports of similar category available with Million Insights: 

  • Pharmaceutical Packaging Market -
  • DNA Vaccines Market -  
  • Adult Vitamins Gummies Market -  
  • Anhydrous Dibasic Calcium Phospate Market -

In 2015, API market was dominated by the North America and is anticipated to retain its position in upcoming years owing to encouraging government initiatives for generic drug usage, rising R&D expenditure, and technological advancements in the drug manufacturing practices.

One of the key manufacturers of the API (Active pharmaceutical ingredients) is Teva Pharmaceuticals Ltd. Some of the additional key players in this industry includes Boehringer Ingelheim GmbH, AbbVie, Inc., Merck & Co., Inc. and Cipla, Inc., New molecule launches, collaborations, acquisitions, and regional expansions are some strategic initiatives taken by these Key players to retain their position.

Market Segment: 

API Type of Synthesis Outlook (Revenue, USD Billion, 2014 - 2025) 

        • Biotech

                • Monoclonal antibodies

                • Recombinant proteins

                • Vaccines

        • Synthetic

API Type of Manufacturer Outlook (Revenue, USD Billion, 2014 - 2025) 

        • Captive APIs

        • Merchant APIs

API Type Outlook (Revenue, USD Billion, 2014 - 2025) 

        • Generic APIs

        • Innovative APIs

API Application Outlook (Revenue, USD Billion, 2014 - 2025) 

        • Cardiovascular Disease

        • Oncology

        • CNS & Neurological Disorders

        • Orthopedic Disorders

        • Endocrinology

        • Pulmonology

        • Gastrointestinal Disorders

        • Nephrology

        • Ophthalmology

API Regional Outlook (Revenue, USD Billion, 2014 - 2025) 

        • North America

                • U.S.

                • Canada

        • Europe

                • Germany

                • UK

        • Asia Pacific

                • China

                • Japan

        • Latin America

                • Mexico

                • Brazil

        • MEA

                • South Africa

About Million Insights: 

Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place, that will enable you to compare data points, before you make a purchase. Enabling informed buying, is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.

Contact: Ryan Manuel Research Support Specialist, USA Million Insights Phone: +1-408-610-2300 Toll Free: 1-866-831-4085 Email:


SOURCE Million Insights

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store